Confirmation that the renin gene distal enhancer polymorphism REN-5312C/T is associated with increased blood pressure

Circulation: Cardiovascular Genetics

Volumn 3, Issue 1, 2010, Pages 53-59

  Vangjeli, Ciara ^a   Clarke, Niamh ^a   Quinn, Ursula ^a   Dicker, Patrick ^b   Tighe, Orna ^a   Ho, Clara ^a   O'Brien, Eoin ^c   Stanton, Alice V ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b Division of Population   (Australia)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Blood pressure; Gene; Genetics; Polymorphism; Population; Renin; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; RENIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENHANCER REGION; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; IRELAND; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ALLELE; BLOOD PRESSURE; CAUCASIAN; GENETICS; MIDDLE AGED; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

MUS MUSCULUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANGIOTENSINOGEN; BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; IRELAND; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 77952534986     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.109.899930     Document Type: Article

References (46)

1. Oparil S, Haber E. The renin-angiotensin system (first of two parts). N Engl J Med. 1974;291:389-401.
2. Oparil S, Haber E. The renin-angiotensin system (second of two parts). N Engl J Med. 1974;291:446-457.
3. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37: 1047-1052.
4. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224-236.
5. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:E1-E9.
6. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238-33243.
7. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277:14838-14843.
8. Schiavone MT, Santos RA, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA. 1988;85:4095-4098.
9. Santos RA, Castro CH, Gava E, Pinheiro SV, Almeida AP, Paula RD, Cruz JS, Ramos AS, Rosa KT, Irigoyen MC, Bader M, Alenina N, Kitten GT, Ferreira AJ. Impairment of in vitro and in vivo heart function in angiotensin-( 1-7) receptor MAS knockout mice. Hypertension. 2006;47:996-1002.
10. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA. 1994;91:3612-3615.
11. Clark AF, Sharp MG, Morley SD, Fleming S, Peters J, Mullins JJ. Renin-1 is essential for normal renal juxtaglomerular cell granulation and macula densa morphology. J Biol Chem. 1997;272:18185-18190.
12. Kessler SP, deS Senanayake, Scheidemantel TS, Gomos JB, Rowe TM, Sen GC. Maintenance of normal blood pressure and renal functions are independent effects of angiotensin-converting enzyme. J Biol Chem. 2003;278:21105-21112.
13. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL, Rockman HA, Coffman TM. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest. 2006;116:2218-2225.
14. Luft FC, Mervaala E, Muller DN, Gross V, Schmidt F, Park JK, Schmitz C, Lippoldt A, Breu V, Dechend R, Dragun D, Schneider W, Ganten D, Haller H. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension. 1999;33:212-218.
15. Jeunemaitre X. Genetics of the human renin angiotensin system. J Mol Med. 2008;86:637-641.
16. Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, Pratt R, Dzau VJ. Genetic markers: progress and potential for cardiovascular disease. Circulation. 2004;109:IV47-IV58.
17. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst. 2004;96:421-423.
18. Moore N, Dicker P, O'Brien JK, Stojanovic M, Conroy RM, Treumann A, O'Brien ET, Fitzgerald D, Shields D, Stanton AV. Renin gene polymorphisms and haplotypes, blood pressure, and responses to renin-angiotensin system inhibition. Hypertension. 2007;50:340-347.
19. O'Brien E, Murphy J, Tyndall A, Atkins N, Mee F, McCarthy G, Staessen J, Cox J, O'Malley K. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens. 1991;9:355-360.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
21. Weale ME, Depondt C, Macdonald SJ, Smith A, Lai PS, Shorvon SD, Wood NW, Goldstein DB. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkagedisequilibrium gene mapping. Am J Hum Genet. 2003;73:551-565.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
23. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, Jayaraman M, Sharma K. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. Jop. 2001;2:83-87.
24. Purcell S. PLINK version 1.04. 2007. Available at: http://pngu.mgh. harvard.edu/purcell/plink/.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
26. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
27. Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155:701-709.
28. Morise T, Takeuchi Y, Takeda R. Frequency of renin gene restriction fragment length polymorphism in hypertensives with a genetic predisposition to hypertension. Horm Res. 1994;41:218-221.
29. Soubrier F, Jeunemaitre X, Rigat B, Houot AM, Cambien F, Corvol P. Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects. Hypertension. 1990;16:712-717.
30. Zee RY, Ying LH, Morris BJ, Griffiths LR. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension. J Hypertens. 1991;9:825-830.
31. Chiang FT, Hsu KL, Tseng CD, Lo HM, Chern TH, Tseng YZ. Association of the renin gene polymorphism with essential hypertension in a Chinese population. Clin Genet. 1997;51:370-374.
32. Naftilan AJ, Williams R, Burt D, Paul M, Pratt RE, Hobart P, Chirgwin J, Dzau VJ. A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. Hypertension. 1989;14:614-618.
33. Fu Y, Katsuya T, Asai T, Fukuda M, Inamoto N, Iwashima Y, Sugimoto K, Rakugi H, Higaki J, Ogihara T. Lack of correlation between Mbo I restriction fragment length polymorphism of renin gene and essential hypertension in Japanese. Hypertens Res. 2001;24:295-298.
34. Berge KE, Berg K. No effect of a BglI polymorphism at the renin (REN) locus on blood pressure level or variability. Clin Genet. 1994;46:436-438.
35. Jeunemaitre X, Rigat B, Charru A, Houot AM, Soubrier F, Corvol P. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet. 1992;88:301-306.
36. Hasimu B, Nakayama T, Mizutani Y, Izumi Y, Asai S, Soma M, Kokubun S, Ozawa Y. Haplotype analysis of the human renin gene and essential hypertension. Hypertension. 2003;41:308-312. (Pubitemid 36204907)
37. Frossard PM, Malloy MJ, Lestringant GG, Kane JP. Haplotypes of the human renin gene associated with essential hypertension and stroke. J Hum Hypertens. 2001;15:49-55.
38. Ahmad U, Saleheen D, Bokhari A, Frossard PM. Strong association of a renin intronic dimorphism with essential hypertension. Hypertens Res. 2005;28:339-344. (Pubitemid 40895056)
39. Zhu X, Chang YP, Yan D, Weder A, Cooper R, Luke A, Kan D, Chakravarti A. Associations between hypertension and genes in the reninangiotensin system. Hypertension. 2003;41:1027-1034.
40. Mansego ML, Redon J, Marin R, Gonzalez-Albert V, Martin-Escudero JC, Fabia MJ, Martinez F, Chaves FJ. Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens. 2008;26:230-237.
41. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT. Population-based sample reveals gene-gender interactions in blood pressure in white Americans. Hypertension. 2007;49:96-106.
42. Germain S, Bonnet F, Philippe J, Fuchs S, Corvol P, Pinet F. A novel distal enhancer confers chorionic expression on the human renin gene. J Biol Chem. 1998;273:25292-25300.
43. Fuchs S, Philippe J, Germain S, Mathieu F, Jeunemaitre X, Corvol P, Pinet F. Functionality of two new polymorphisms in the human renin gene enhancer region. J Hypertens. 2002;20:2391-2398.
44. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, Aulchenko Y, Lumley T, Kottgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, Arking DE, Mitchell GF, Mattace-Raso FU, Smith AV, Taylor K, Scharpf RB, Hwang SJ, Sijbrands EJ, Bis J, Harris TB, Ganesh SK, O'Donnell CJ, Hofman A, Rotter JI, Coresh J, Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JC, Boerwinkle E, Wang TJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, van Duijn CM. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687.
45. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678.
46. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, Shi X, Pan L, Rampersaud E, Shen H, Kim JD, Subramanya AR, Steinle NI, Parsa A, Ober CC, Welling PA, Chakravarti A, Weder AB, Cooper RS, Mitchell BD, Shuldiner AR, Chang YP. From the cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA. 2009;106:226-231.